Cite
HARVARD Citation
Qadir, M. et al. (2016). Advantage of pegylated interferon and ribavirin combination therapy in people living with hepatitis C virus/HIV coinfection. Reviews in medical microbiology. 27 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Qadir, M. et al. (2016). Advantage of pegylated interferon and ribavirin combination therapy in people living with hepatitis C virus/HIV coinfection. Reviews in medical microbiology. 27 (1), p. . [Online].